Formlabs Finished Building a Public-Company Board Before Confirming an IPO

A founder hands over the chairman's seat and takes an advisory one. A chief product officer becomes president and joins the board. A former Apple hardware chief writes a personal cheque. Formlabs published all of it on a single day, days after Bloomberg reported the company was in early talks with advisers about a US listing. The order of events is the story: this is the governance work a private company finishes before it files, not the cleanup it does after a credibility shock.

Chairman, President, Advisor: What Formlabs Announced on August 12

Four things moved at once. Co-founder Maxim Lobovsky, already CEO, assumed the chairman title. Co-founder Natan Linder gave it up after roughly fifteen years and transitioned into an advisor role, as reported by 3D Printing Industry in August 2026. Chief Product Officer Dávid Lakatos was named President and appointed to the Board of Directors. And Dan Riccio, Apple's former Senior Vice President of Hardware Engineering, joined as a strategic advisor and — the detail that carries more weight than the title — as an investor, with sitting board member Rob Willett making an investment alongside him (company press release, Somerville, Massachusetts, Aug 12, 2026).

The same release describes Formlabs as the largest supplier of professional SLA and SLS 3D printing systems in the world. That is a self-assessment rather than an audited share figure, but it is the sentence a company drafts when it is rehearsing prospectus language.

Our own coverage counters register the shift in tempo. The AM Pulse news pipeline logged 18 items from companies name-matching "Formlabs" in the last 180 days, against 2 in the 180 days before that — a name-match, not a sector filter, but a steep change in tempo for a company that has made little capital-markets news since its 2021 funding round. Our patent linkage associates 115 active patent records with Formlabs; that linkage is name-matched and review-gated, so it undercounts subsidiaries and transliterated applicant names.

Why a President and a Combined Chairman-CEO Point at an S-1

Each individual change has a mundane private-company reading. Together they form a structure that only makes sense on a public register.

Merging the CEO and chairman roles in one founder is not, on its own, investor-friendly — US institutional governance practice treats it as a concentration risk, and the standard offset is a designated lead director with independent standing. Formlabs' August announcement includes exactly that construct. A lead director has almost no function inside a private company with a concentrated cap table; it exists to give public shareholders a counterweight. Naming one now is the cleanest single tell in the package.

Elevating a chief product officer to president does two things at once. It gives a filing a named operating executive distinct from the founder-CEO, and it frees the founder for the roadshow calendar. Lakatos's board seat, meanwhile, converts the product organisation into a governance voice at the moment product mix is the argument: the company's push from desktop resin into industrial powder-bed polymer, which we examined in our Fuse X1 cost-curve analysis, is the revenue narrative any listing would have to carry. Riccio's arrival supplies the third ingredient — an operator who has shipped hardware at consumer volume, whose presence in a prospectus reads as manufacturing credibility rather than a logo.

Pricing Formlabs Against Stratasys, 3D Systems, and the SPAC Cohort

The comparison set is the problem. Desktop Metal, Markforged, Velo3D and Shapeways all reached public markets in 2020–2022 through reverse mergers priced on forward projections, and by 2025–2026 had resolved into restructuring, acquisition, pivot or delisting. Desktop Metal is the cautionary case: the numbers investors underwrote were never the numbers the business produced. Formlabs differs in the two ways that matter — a decade-plus operating history with a disclosed revenue base, and a conventional underwritten process where the diligence happens before the shares trade rather than in the second year of missed guidance.

The incumbent comps are no easier. Stratasys is running roughly flat with thin operating margins, and 3D Systems' recent improvement has come from restructuring and dispositions rather than broad commercial growth. Neither offers a multiple a 2021-vintage investor would want applied to their entry price.

Creality's Hong Kong debut earlier this year is the nearer benchmark, and the axis is instructive: same value-chain position — printer OEM selling hardware plus consumables to non-industrial buyers — but priced on volume-driven consumer economics in an Asian venue. Formlabs would sell a professional customer base at far higher average selling prices on a US exchange. Set against Beijing Yuding Additive Manufacturing and Sanlu, whose dual STAR and ChiNext filings we covered in June, the variable being isolated is venue and investor base, not technology.

The Case That Formlabs Never Files

Bloomberg's report describes early talks with potential advisers and states no final decision has been made. Companies restructure boards and then do not file; SoftBank-backed listing explorations have stalled before, and a 2026–27 window may simply not offer a price the 2021 Series E investors will accept.

The ordinary explanation also survives scrutiny. A founder-chairman relationship that runs fifteen years often ends for reasons unconnected to capital markets, and Linder has an active separate venture in Tulip Interfaces. Reading a board refresh as a filing calendar requires the lead-director and president changes to be doing the work; strip those two out and what remains is a founder stepping back.

The weakest link is Riccio himself. He joined as a strategic advisor and personal investor — not as a director. An advisory seat carries no fiduciary duty, appears in no proxy, and can be unwound without disclosure. Had he taken a board seat, the IPO reading would be close to unambiguous; as structured, it is signalling with an exit.

What is verifiable is the sequence. Governance conversion completed, product line moved upmarket, insiders adding exposure, no filing yet. Anyone pricing Western polymer AM should be building the comparable now rather than after the S-1 lands.